Literature DB >> 21866176

Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast.

B Walch1, T Breinig, M J Schmitt, F Breinig.   

Abstract

Among the different vaccination approaches, DNA/RNA vaccination represents a promising means in particular for the induction of effective cellular immune responses conferred by CD8-positive T lymphocytes. To achieve such immune responses, there is a need for novel delivery systems that allow the introduction of nucleic acids to the cytosol of immune cells. We show, for the first time, the delivery of functional DNA and messenger RNA (mRNA) to mammalian antigen-presenting cells, including murine macrophages and human dendritic cells, using the yeast Saccharomyces cerevisiae as the delivery vehicle. After transfer of the particular nucleic acid, subsequent antigen processing and presentation were demonstrated in a human system. Remarkably, release of DNA/mRNA does not require additional 'helper' proteins such as listeriolysin. In conclusion, the yeast-based system described here is superior to many bacterial and viral systems in terms of efficacy, safety and targeting suggesting 'mycofection' as a promising approach for the development of a novel type of live vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866176     DOI: 10.1038/gt.2011.121

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  10 in total

1.  Maturation and cytokine pattern of human dendritic cells in response to different yeasts.

Authors:  Silvia Boschi Bazan; Barbara Walch-Rückheim; Manfred J Schmitt; Frank Breinig
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

Review 2.  Messenger RNA (mRNA) nanoparticle tumour vaccination.

Authors:  Kyle K L Phua; Smita K Nair; Kam W Leong
Journal:  Nanoscale       Date:  2014-07-21       Impact factor: 7.790

3.  Coexpression of human perforin improves yeast-mediated delivery of DNA and mRNA to mammalian antigen-presenting cells.

Authors:  B Walch-Rückheim; R Kiefer; G Geginat; M J Schmitt; F Breinig
Journal:  Gene Ther       Date:  2015-08-20       Impact factor: 5.250

4.  Yeast (Saccharomyces cerevisiae) Polarizes Both M-CSF- and GM-CSF-Differentiated Macrophages Toward an M1-Like Phenotype.

Authors:  Michelle Seif; Anja Philippi; Frank Breinig; Alexandra K Kiemer; Jessica Hoppstädter
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

5.  Saccharomyces cerevisiae (Baker's Yeast) as an Interfering RNA Expression and Delivery System.

Authors:  Molly Duman-Scheel
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

Review 6.  Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?

Authors:  Yannick Willemen; Maarten Versteven; Marc Peeters; Zwi N Berneman; Evelien L J Smits
Journal:  Cancers (Basel)       Date:  2020-01-27       Impact factor: 6.639

7.  Rescue of Infectious Sindbis Virus by Yeast Spheroplast-Mammalian Cell Fusion.

Authors:  Lin Ding; David M Brown; John I Glass
Journal:  Viruses       Date:  2021-04-01       Impact factor: 5.048

Review 8.  Yeasts in nanotechnology-enabled oral vaccine and gene delivery.

Authors:  Elena Ivanova
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity.

Authors:  Kyle K L Phua; Herman F Staats; Kam W Leong; Smita K Nair
Journal:  Sci Rep       Date:  2014-06-04       Impact factor: 4.379

10.  In vivo targeted delivery of CD40 shRNA to mouse intestinal dendritic cells by oral administration of recombinant Sacchromyces cerevisiae.

Authors:  L Zhang; T Zhang; L Wang; S Shao; Z Chen; Z Zhang
Journal:  Gene Ther       Date:  2014-05-29       Impact factor: 5.250

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.